Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes
Authors
Keywords
-
Journal
American Journal of Hospice & Palliative Medicine
Volume -, Issue -, Pages 104990911983897
Publisher
SAGE Publications
Online
2019-03-28
DOI
10.1177/1049909119838974
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe opioid withdrawal precipitated by Vivitrol®
- (2018) R.S. Wightman et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy
- (2018) Zijian Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
- (2018) Mitchell R. K. L. Lie et al. Journal of Translational Medicine
- The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders
- (2018) Denise K. Patten et al. PHARMACOTHERAPY
- The effect of naltrexone as a carboplatin chemotherapy-associated drug on the immune response, quality of life and survival of dogs with mammary carcinoma
- (2018) Marília Carneiro Machado et al. PLoS One
- Systematic review and meta-analysis on non-opioid analgesics in palliative medicine
- (2018) Robert H. Schüchen et al. Journal of Cachexia Sarcopenia and Muscle
- Featured Article: Serum [Met5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone
- (2017) Michael D Ludwig et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants
- (2017) David Mischoulon et al. JOURNAL OF AFFECTIVE DISORDERS
- A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study
- (2016) Guttorm Raknes et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
- (2014) Jarred Younger et al. CLINICAL RHEUMATOLOGY
- Modulating the delicate glial–neuronal interactions in neuropathic pain: Promises and potential caveats
- (2014) Vinod Tiwari et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Off-Label, Low-Dose Naltrexone for Refractory Chronic Low Back Pain
- (2014) Babita Ghai et al. PAIN MEDICINE
- Low-dose naltrexone for the treatment of fibromyalgia: Findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels
- (2013) Jarred Younger et al. ARTHRITIS AND RHEUMATISM
- Treatment of Complex Regional Pain Syndrome (CRPS) Using Low Dose Naltrexone (LDN)
- (2013) Pradeep Chopra et al. Journal of Neuroimmune Pharmacology
- Release of endogenous opioids during a chronic IBD model suppresses the excitability of colonic DRG neurons
- (2012) E. Valdez-Morales et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Opioid receptors: distinct roles in mood disorders
- (2012) Pierre-Eric Lutz et al. TRENDS IN NEUROSCIENCES
- The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial
- (2010) Naser Sharafaddinzadeh et al. Multiple Sclerosis Journal
- Fibromyalgia Symptoms Are Reduced by Low-Dose Naltrexone: A Pilot Study
- (2009) Jarred Younger et al. PAIN MEDICINE
- Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)
- (2008) Mark R. Hutchinson et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Opioids and the treatment of chronic pain: Controversies, current status, and future directions.
- (2008) Andrew Rosenblum et al. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY
- The Opioid Antagonist Naltrexone Improves Murine Inflammatory Bowel Disease
- (2008) Gail L. Matters et al. Journal of Immunotoxicology
- Low-dose naltrexone for disease prevention and quality of life
- (2008) Norman Brown et al. MEDICAL HYPOTHESES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started